QI
AMRI

Quotient Investors’s Albany Molecular Research Inc AMRI Stock Holding History

Quotient Investors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,800
Closed -$201K – 285
2014
Q1 		$201K Hold
10,800
– – 0.05% 218
2013
Q4 		$109K Buy
+10,800
New +$131K 0.03% 237

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Quotient Investors's AMRI Position: Q2 2014 in Review

Quotient Investors sold out of Albany Molecular Research Inc (AMRI) in Q2 2014, closing a stake of 10,800 shares — an estimated $201K sold.

Quotient Investors first reported a position in AMRI in Q4 2013 and held it in 2 quarters. The position peaked at $201K in Q1 2014. 132 funds tracked by Wall St. Rank hold AMRI as of Q2 2014.

  • Quotient Investors reported no remaining Albany Molecular Research Inc position as of Q2 2014 after selling out during the quarter.
  • Quotient Investors sold 10,800 Albany Molecular Research Inc shares in Q2 2014, an estimated $201K.
  • Quotient Investors first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 2 quarters.
  • Quotient Investors's Albany Molecular Research Inc position peaked at $201K in Q1 2014.
  • 132 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2014.

Based on Quotient Investors's 13F filing for Q2 2014, filed 18 Jul 2014.